產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-C6orf130抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-C6orf130抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-C6orf130
Cat. Number:
Anti-C6orf130抗體KL-15217R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
C6orf130 is a Making up nearly 6% of the human genome, chromosome 6 contains around 1,200 genes within 170 million base pairs of sequence. Deletion of a portion of the q arm of chromosome 6 is associated with early onset intestinal cancer suggesting the presence of a cancer susceptibility locus.Anti-C6orf130抗體 Porphyria cutanea tarda is associated with chromosome 6 through the HFE gene which, when mutated, predisposes an individual to developing this porphyria. Notably, the PARK2 gene, which is associated with Parkinson's disease, and the genes encoding the major histocompatiblity complex proteins, which are key molecular components of the immune system and determine predisposition to rheumatic diseases, are also located on chromosome 6. Stickler syndrome, 21-hydroxylase deficiency and maple syrup urine disease are also associated with genes on chromosome 6. A bipolar disorder susceptibility locus has been identified on the q arm of chromosome 6. The C6orf130 gene product has been provisionally designated C6orf130 pending further characterization.
Also known as:
C6orf130; OARD1_HUMAN; Anti-C6orf130抗體Chromosome 6 open reading frame 130; dJ34B21.3; O acetyl ADP ribose deacetylase C6orf130; Uncharacterized protein C6orf130.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Horse, Rabbit, .
●
Immunogen: KLH conjugated synthetic peptide derived from human C6orf130.
●
Predicted Molecular Weight: 17kDa.
Storage:
Shipped at 4℃, Store at -20℃ Anti-C6orf130抗體(Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutionsAnti-C6orf130抗體 must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutionsAnti-C6orf130抗體 must be determined by the end user.
kl553Hu06 基質(zhì)金屬蛋白酶9(MMP9)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 9 (MMP9)
kl682Ra01 胱天蛋白酶12(CASP12)多克隆抗體 Polyclonal Antibody to Caskle 12 (CASP12)
kl207Ra01 C-型凝集素域家族2成員C(CLEC2C)多克隆抗體 Polyclonal Antibody to C-Type Lectin Domain Family 2, Member C (CLEC2C)
kl310Ra01 彈性蛋白酶4(ELA4)多克隆抗體 Polyclonal Antibody to Elastase 4 (ELA4)
kl399Mu01 白細(xì)胞**球蛋白樣受體亞家族B成員4(LILRB4)多克隆抗體 Polyclonal Antibody to Leukocyte Immunoglobulin Like Receptor Subfamily B, Member 4 (LILRB4)
kl401Mu01 原鈣黏素β2(PCDHβ2)多克隆抗體 Polyclonal Antibody to Protocadherin Beta 2 (PCDHb2)
kl525Mu01 巨噬細(xì)胞刺激1受體(MST1R)多克隆抗體 Polyclonal Antibody to Macrophage Stimulating 1 Receptor (MST1R)
kl556Ra01 大型多功能肽酶7(LMP7)多克隆抗體 Polyclonal Antibody to Large Multifunctional Peptidase 7 (LMP7)
kl578Mu01 IgG-Fc片段受體Ⅰ(FcγRⅠ)多克隆抗體 Polyclonal Antibody to Receptor I For The Fc Region Of Immunoglobulin G (FcgRI)
kl807Ra01 巖藻糖苷酶αL1(FUCα1)多克隆抗體 Polyclonal Antibody to Fucosidase Alpha L1, Tissue (FUCa1)
kl841Ra01 含血管性血友病因子A域蛋白1(vWA1)多克隆抗體 Polyclonal Antibody to Von Willebrand Factor A Domain Containing Protein 1 (vWA1)
kl871Mu01 熱休克蛋白β2(HSPβ2)多克隆抗體 Polyclonal Antibody to Heat Shock Protein Beta 2 (HSPb2)
kl371Mu01 轉(zhuǎn)醛縮酶(TALDO1)多克隆抗體 Polyclonal Antibody to Transaldolase (TALDO1)
kl400Mu01 絲氨酸蛋白酶12(PRSS12)多克隆抗體 Polyclonal Antibody to Protease, Serine 12 (PRSS12)
kl410Mu01 CD97分子(CD97)多克隆抗體 Polyclonal Antibody to Cluster Of Differentiation 97 (CD97)
kl444Mu01 核糖核酸抑制因子(RI)多克隆抗體 Polyclonal Antibody to Ribonuclease Inhibitor (RI)
kl528Mu01 親環(huán)素D(CYPD)多克隆抗體 Polyclonal Antibody to Cyclophilin D (CYPD)
kl528Ra01 親環(huán)素D(CYPD)多克隆抗體 Polyclonal Antibody to Cyclophilin D (CYPD)
